women's health
| 2 min read
FDA greenlights Bayer’s first-in-class drug and non-hormonal option in the vasomotor-symptom space.
| 3 min read
Point-of-care tests that detect biomarkers from menstrual blood can enable broader access to disease monitoring and diagnosis.
| 4 min read
Learn about the Teal Wand™, an FDA-approved at-home HPV test from Teal Health. This self-collection test is expanding access to cervical cancer screening.
| 4 min read
By identifying high-risk pregnancies early, Mirvie’s new RNA-based test opens the door to timely prevention.
| 4 min read
Placental extracellular vesicles from maternal blood plasma identified women who would go on to develop complications later in their pregnancy.
| 6 min read
Sabrina Johnson at Daré Bioscience is redefining contraception with Ovaprene, a non-hormonal, monthly option for safe and effective birth control.
| 8 min read
Lundbeck Therapeutics is testing a monoclonal antibody that targets a novel neuropeptide in a Phase 2b clinical trial.
| 8 min read
Bacteria from healthy vaginas show promise in protecting women from pathogens, but advancing their development requires more funding and research.
| 5 min read
Industry leaders predict the most exciting advances in drug discovery and development in the coming year.
| 3 min read
Doctors have been treating bacterial vaginosis with the same antibiotic for decades. This fatty acid could change that.
